Dec 30, 2019
Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors
Dec 03, 2019
Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference
Nov 14, 2019
Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results
Nov 07, 2019
Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow
Oct 16, 2019
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering
Oct 01, 2019
Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities
Sep 18, 2019
Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant
Aug 14, 2019
Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results
Aug 07, 2019
Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering
Jul 09, 2019
Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark
Jun 26, 2019
Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine
Jun 04, 2019
Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®
May 15, 2019
Titan Pharmaceuticals Reports First Quarter 2019 Financial Results
May 13, 2019
Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®
May 08, 2019
Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow
Apr 29, 2019
Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®
Apr 01, 2019
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
Mar 28, 2019
Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services
Mar 26, 2019
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019
Feb 25, 2019
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®